Vaccines

Healthcare Champions Kick Off 2024
Contaminated Vaccines: FDA Reportedly Finds Cleaning And Expiry Lapses At Moderna's Massachusetts Facility
China's mRNA Pioneer Stemirna Faces Post-Covid Reinvention Test
Contaminated Vaccines: FDA Reportedly Finds Cleaning And Expiry Lapses At Moderna's Massachusetts Facility
China's mRNA Pioneer Stemirna Faces Post-Covid Reinvention Test
Mainz Biomed To Present The Power Of mRNA That Promises To Revolutionize Medicine
More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone

Vaccines Recent News

FDA Votes In Favor Of Pfizer's Maternal RSV Vaccine To Prevent Disease In Infants
The U.S.
Bill Gates Says Providing nOPV2-Like Vaccines To 'Zero-Dose' Children Will Usher In 'Healthier Future For Us All'
Bill Gates says we must immunize children who have not been vaccinated before to eradicate polio, a move that he says is essential to ensuring a "healthier future for us all."
NFL's Aaron Rodgers' Hail Mary For 2024 Presidential Election: Fellow Anti-Vaxxer Robert Kennedy Jr.
A leading National Football League player has shown early support for a presidential candidate ahead of the 2024 election. Here’s who quarterback Aaron Rodgers is supporting and how one important platform plays into the potential support. 
Jim Cramer Says He's Known Novavax Is 'Worthless' For 'Very Long Time,' Trashes Company For Being Too 'Promotional'
Novavax Inc (NASDAQ: NVAX) shares are crashing Wednesday after the company warned that substantial doubt exists regarding its ability to continue.  Jim Cramer isn't surprised.
EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch
Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information. For some, this is overwhelming.
US Stocks Show Cautious Optimism As S&P 500, Dow Futures Surge Ahead Of Key CPI Data — Trump's SPAC Partner, Applied Materials And Chip Stocks In Focus Today
The U.S. index futures are pointing to a higher opening on Wall Street, reflecting traders’ hopes that the consumer price inflation data may prove benign.
Former Disney Employees Sue Over Vaccine, Mask Rules
Three former Florida-based employees of the Walt Disney Co. (NYSE: DIS) have filed a lawsuit claiming that they were fired after challenging the company’s pandemic-era rules o
J&J Serves Notice To Emergent For Terminating COVID-19 Shot Contract As Two Accuse Each Other Of Breach Of Agreement
Johnson & Johnson (NYSE: JNJ) has made another move towards severing its Covid-19 vaccine manufacturing ties with contract manufacturer Emergent Biosolutions, Inc. (NYSE: EBS).
Pfizer To Boost Production Of Oral COVID-19 Pill With $120M Michigan Investment
Pfizer, Inc. (NYSE: PFE) is upping its commitment to manufacture its oral COVID-19 pill Paxlovid in the United States.
EXCLUSIVE: Tonix CEO Seth Lederman On The Pursuit Of New Monkeypox, COVID Vaccines
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a Chatham, New Jersey-based clinical-stage biopharmaceutical company, announced on Wednesday the issuance of a patent that forms the basis for the company's developmental vaccine against monkeypox and smallpox. 
Novavax's 22% Post-Earnings Plunge: 5 Factors That Took Toll
Novavax, Inc. (NASDAQ: NVAX) shares slumped 22.27% after-hours on Monday, reacting to its quarterly financial report.
Pfizer Could Seek COVID-19 Vaccine Emergency Approval For Children Under 5 This Week
Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) are likely to submit a request for an emergency use authorization to the U.S.
Novavax Scores Approval From Australian Regulator For COVID-19 Vaccine
Novavax Inc (NASDAQ: NVAX) said Wednesday that Australia’s national drugs regulator has granted approval for its COVID-19 vaccine.
Why 'Boycott Starbucks' Is Trending On Twitter Today
The hashtag “Boycott Starbucks” is trending on Twitter Inc.’s (NYSE: TWTR) social media platform in the U.S.
Why Moderna, Novavax And Other Vaccine Stocks Are Extending Losses Today
COVID-19 vaccine stocks are all retreating sharply for a second day running on Friday.
Coalition Of Doctors Complain To Spotify Over COVID 'Misinformation' On Joe Rogan's Podcast
A coalition of 270 doctors, professors, scientists, health care professionals and science communicators have complained to Spotify Technologies S.A. (NASDAQ: SPOT) over what they perceived as medical misinformation being spread on “The Joe Rogan Experience,” the podcast network&
UK Reports First Omicron Death, PM Johnson Encourages Boosters
U.K. Prime Minister Boris Johnson has announced his nation’s first death from the omicron variant of COVID-19. What Happened: The BBC reported that Johnson alerted reporters to the fatality during a visit to a vaccination center.
Elon Musk's Appeal To Workers, New Moderna COVID-19 Vaccine, Bitcoin Rebound, Apple Glasses, US Jobs Data: 5 Headlines You May Have Missed From The Weekend
Heading into a new trading week, here is a quick roundup of the top five stories from the technology, corporate and cryptocurrency sectors that investors would not want to miss out on from the weekend.
Moderna Up Over 8% On Strong Options Volume
Moderna Inc (NASDAQ: MRNA) is having a strong start to the week, up more than 7% Monday on heavy volume. Thus far, the stock has traded over 11 million shares versus its 10 day average of 8 million.
Moderna Cracks Below Support, Is A Recovery In Sight?
Moderna Inc (NASDAQ: MRNA) shares are trading lower Thursday after the company announced its COVID-19 sales came in short of Wall Street analysts estimates by more than $1 billion.
Corona Doom 2.0: Carter Worth Warns That Vaccine-Maker Moderna May Have Further To Fall. What To Do If You're Long.
Moderna: Look Out Below? COVID-19 vaccine maker Moderna, Inc. (NASDAQ: MRNA) was our top name in late August...
FDA Approves Moderna, Johnson & Johnson Booster And 'Mix And Match' COVID-19 Shots
The U.S.
Is This Going To Be The Next Big Factor For Ocugen (OCGN) Stock?
Shares of biopharmaceutical company Ocugen Inc. (NASDAQ: OCGN) surged almost 18.5% in Tuesday’s regular trading session, extending gains to a second straight day.